Tradjenta is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Tradjenta is not for treating type 1 diabetes. Tradjenta can cause severe, life-threatening pancreatitis (inflammation of your pancreas).

TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. TRADJENTA is not for people with type 1 diabetes mellitus.

Trajenta is a medicine that contains the active substance linagliptin. It is available as tablets (5 mg). What is Trajenta used for? Trajenta is used to treat type-2 diabetes with the following …

2025年2月7日 · Tradjenta (linagliptin) is a prescription medication that's used along with a balanced diet and exercise to manage blood sugar levels in adults with Type 2 diabetes. It's a type of diabetes medication called a dipeptidyl peptidase-4 (DPP-4) inhibitor. The dose is 5 mg (1 tablet) that's taken by mouth once per day.

Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat type 2 diabetes (but not type 1) in conjunction with exercise and diet. [8][9] Linagliptin is a dipeptidyl peptidase-4 inhibitor [8] that works by increasing the production of insulin and decreasing the production of glucagon by the pancreas. [8] .

2024年7月17日 · Tradjenta is a brand-name tablet prescribed for type 2 diabetes. Tradjenta contains the active ingredient linagliptin. Tradjenta is FDA-approved to help manage blood sugar levels in adults with...

Linagliptin is a medication that treats type 2 diabetes by increasing insulin levels in your body. It can also reduce how much sugar gets released into your blood. A healthcare provider may recommend changes to your diet and exercise if you take this medication. It comes in a tablet form. What is this medication?

TRADJENTA is a DPP-4 inhibitor indicated, along with diet and exercise, to improve glycemic control in adults with T2D. See ISI, PI and Med Guide.

TRADJENTA tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1)]. TRADJENTA should not be used in...

2024年6月1日 · Trajenta is used to lower blood sugar levels in patients with type 2 diabetes mellitus. It may be used when diet plus exercise do not provide adequate blood sugar level control either: - metformin plus sodium-glucose transporter 2 inhibitor medicines such as empagliflozin.